Beam Therapeutics Inc. Common Stock (BEAM) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for BEAM. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 270 institutions reported holding BEAM, with 109.4 million shares worth $3.8 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR | 12,609,002 | $433M | INCREASED |
| Vanguard | 10,392,262 | $357M | INCREASED |
| Farallon Capital Management | 10,236,396 | $351M | INCREASED |
| ARK Invest | 10,234,862 | $351M | DECREASED |
| BlackRock | 8,997,542 | $309M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| John M. Evans (CEO) | EXERCISE | 25,000 | $26K | 2026-10-16 |
| John M. Evans (CEO) | SELL | 25,000 | $600K | 2026-10-16 |
| John M. Evans (CEO) | EXERCISE | 25,000 | $26K | 2026-10-16 |
| John M. Evans (CEO) | EXERCISE | 25,000 | $26K | 2026-10-15 |
| John M. Evans (CEO) | SELL | 25,000 | $589K | 2026-10-15 |
Full institutional holdings, insider history, and congressional trades for Beam Therapeutics Inc. Common Stock on SentiSense.